ScholarIQanswers from OpenAlex
European Urology Oncology
JournalCitation impact & published research
European Urology Oncology is a journal indexed in ScholarIQ from OpenAlex.
What is the OpenAlex record for European Urology Oncology?
ScholarIQopenalex
The OpenAlex for European Urology Oncology is on the source record.
What are the most-cited papers on European Urology Oncology?
ScholarIQmost cited works
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy
Sue Ping Thang, John Violet, Shahneen Sandhu, Amir Iravani, Tim Akhurst, Grace Kong, Aravind Ravi Kumar, Declan G. Murphy, Scott Williams, Rodney J. Hicks, Michael S. Hofman
Three-dimensional Model–assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies
Federico Piramide, Karl‐Friedrich Kowalewski, Giovanni Cacciamani, I. Rivero Belenchón, Mark Taratkin, Umberto Carbonara, Michele Marchioni, Ruben De Groote, Sophie Knipper, Angela Pecoraro, Filippo Turri, Paolo Dell’Oglio, Stefano Puliatti, Daniele Amparore, G. Volpi, Riccardo Campi, Alessandro Larcher, Alex Mottrie, Alberto Breda, Andrea Minervini, Ahmed Ghazi, Prokar Dasgupta, Ali Gozen, Riccardo Autorino, Cristian Fiori, Michele Di Dio, Juan Gómez Rivas, Francesco Porpiglia, Enrico Checcucci
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review
Maria Monica Ratti, Giorgio Gandaglia, Eugenia Alleva, Luca Leardini, Elena Silvia Sisca, Alexandra Derevianko, Federica Furnari, Serena Mazzoleni Ferracini, Katharina Beyer, Charlotte Moss, Francesco Pellegrino, Gabriele Sorce, Francesco Barletta, Simone Scuderi, Muhammad Imran Omar, Steven MacLennan, Paula Williamson, Jihong Zong, Sara MacLennan, Nicolas Mottet, Philip Cornford, Olalekan Lee Aiyegbusi, Mieke Van Hemelrijck, James N’Dow, Alberto Briganti
Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration
Nancy Vander Velde, Annie Guérin, Raluca Ionescu‐Ittu, Sherry Shi, Eric Q. Wu, Shih‐Wen Lin, Ling‐I Hsu, Kai‐Uwe Saum, Sabine de Ducla, Jingjing Wang, Shi Li, AnnChristine Thåström, Shuqian Liu, Lizheng Shi, John T. Leppert
Current Treatment Paradigms and Clinical Outcomes in Oligometastatic Prostate Cancer Patients: A Targeted Literature Review
Emmanuel S. Antonarakis, Irene M. Shui, Omer Zaidi, Mark Bernauer, Christian Gratzke